EVH:NYE-Evolent Health Inc Class A (USD)

EQUITY | Health Information Services | New York Stock Exchange

Last Closing

USD 11.32

Change

-0.09 (-0.79)%

Market Cap

USD 1.38B

Volume

1.58M

Analyst Target

USD 11.67
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Evolent Health Inc is engaged in healthcare delivery and payment. It markets and sells its services to providers throughout the United States.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-23 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap
SOLV Solventum Corp.

-0.20 (-0.30%)

USD 10.78B
DOCS Doximity Inc

+0.35 (+0.61%)

USD 10.37B
WEAV Weave Communications Inc

+0.07 (+0.43%)

USD 1.13B
AMWL American Well Corp

-0.43 (-5.46%)

USD 0.15B
MPLN MultiPlan Corporation

+0.26 (+4.32%)

USD 0.12B
OWLT Owlet Inc

N/A

USD 0.08B
ICCT iCoreConnect Inc. Common stock

+2.68 (+2,248.15%)

USD 2.90M
TDOC Teladoc Inc

-0.32 (-3.39%)

N/A
FOXO FOXO Technologies Inc.

-0.01 (-1.96%)

N/A
PHR Phreesia Inc

+0.22 (+0.87%)

N/A

ETFs Containing EVH

ACTV LeaderShares® Activist L.. 0.00 % 0.00 %

-0.02 (-0.06%)

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health Information Services) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -65.73% 36% F 2% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -65.73% 36% F 2% F
Trailing 12 Months  
Capital Gain -64.71% 36% F 2% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -64.71% 36% F 2% F
Trailing 5 Years  
Capital Gain 29.82% 80% B- 66% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 29.82% 80% B- 56% F
Average Annual (5 Year Horizon)  
Capital Gain 41.76% 100% F 91% A-
Dividend Return 41.76% 100% F 91% A-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 73.98% 50% F 12% F
Risk Adjusted Return 56.45% 100% F 71% C-
Market Capitalization 1.38B N/A N/A N/A N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Health Information Services) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio N/A N/A N/A
Price/Book Ratio N/A N/A N/A
Price / Cash Flow Ratio N/A N/A N/A
Price/Free Cash Flow Ratio N/A N/A N/A
Management Effectiveness  
Return on Equity N/A N/A N/A
Return on Invested Capital N/A N/A N/A
Return on Assets N/A N/A N/A
Debt to Equity Ratio N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.